Back to Trades
Other4
Organon & Co.
OGN
Total Value
$32.3K
Company Information
- Company Name
- Organon & Co.
- Ticker Symbol
- OGN
- CIK
- 0001821825
Insider Information
- Name
- Karp Daniel
- Role
- Executive VP, Corp. Dev.
- Location
- JERSEY CITY, NJ
Officer
Filing Details
- Filing Date
- Apr 2, 2026
- Transaction Date
- Mar 31, 2026
- Accession Number
- 0001628280-26-023180
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | 11,338 | — | Exercise | — |
| Mar 31, 2026 | Common Stock | 3,554 | $5.70 | Tax Withholding | $20.3K |
| Mar 31, 2026 | Common Stock | 6,715 | — | Exercise | — |
| Mar 31, 2026 | Common Stock | 2,105 | $5.70 | Tax Withholding | $12.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Derivative | 100,166 | — | Grant/Award | — |
| Mar 31, 2026 | Derivative | 11,338 | — | Exercise | — |
| Mar 31, 2026 | Derivative | 6,715 | — | Exercise | — |
Footnotes
- (F1)The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- (F2)On March 31, 2026, the Reporting Person was granted 100,166 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
- (F3)Each RSU represents a contingent right to receive one share of Organon common stock.
- (F4)On March 31, 2023, the Reporting Person was granted 34,014 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026.
- (F5)On March 31, 2025, the Reporting Person was granted 20,147 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.